Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for osteoinduction.

Sanjay Kumar1, Selvarangan Ponnazhagan

  • 1Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Current Gene Therapy
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide.

Journal of pharmaceutical and biomedical analysis·2014
Same author

Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.

PloS one·2014
Same author

Development of bile duct bezoars following cholecystectomy caused by choledochocolonic fistula formation.

Annals of gastroenterology·2014
Same author

Hepatic pulmonary fusion: a rare association of right-sided congenital diaphragmatic hernia.

Annals of gastroenterology·2014
Same author

Idiopathic cystic artery aneurysm complicated with hemobilia.

Annals of gastroenterology·2014
Same author

Spatial distribution of persistent organic pollutants in the surface water of River Brahmaputra and River Ganga in India.

Reviews on environmental health·2014
Same journal

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.

Current gene therapy·2026
Same journal

GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.

Current gene therapy·2026
Same journal

Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.

Current gene therapy·2026
Same journal

Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.

Current gene therapy·2026
Same journal

Screening and Functional Study of Biomarkers Related to Cell-in-cell Structure in Stomach Adenocarcinoma.

Current gene therapy·2026
Same journal

HOXC4 Is Associated with the Prognosis and Immune Cell Infiltration in the Progression of Prostate Cancer.

Current gene therapy·2026
See all related articles

Gene therapy offers a promising approach for bone and mineral metabolism disorders by correcting defective genes. This review explores vector-mediated gene therapy strategies for bone diseases, focusing on safety and efficacy.

Area of Science:

  • Genetics
  • Molecular Biology
  • Orthopedics

Background:

  • Bone and mineral metabolism disorders often stem from genetic defects affecting cellular growth and differentiation.
  • Current osteoinduction therapies are primarily pharmacological, with limited molecular targeting capabilities.

Purpose of the Study:

  • To provide a comprehensive review of existing osteoinduction therapies.
  • To discuss the potential and limitations of vector-mediated gene therapy for bone diseases.

Main Methods:

  • Review of current literature on gene therapy approaches for bone disorders.
  • Analysis of key considerations for gene therapy: gene introduction, immunogenicity, toxicity, regulated expression, and gene silencing.
  • Evaluation of vector-mediated delivery systems for therapeutic genes.

Related Experiment Videos

Main Results:

  • Gene therapy can compensate for defective genes by introducing normal copies.
  • Key considerations for successful gene therapy include non-alteration of native gene properties, minimal adverse effects, targeted expression, and gene silencing capabilities.
  • Molecular understanding of biologically-driven factors enhances potential therapeutic protein development.

Conclusions:

  • Vector-mediated gene therapy presents a significant potential for treating bone diseases by addressing underlying genetic defects.
  • Careful evaluation of strategies is crucial for optimizing therapeutic outcomes and minimizing risks.
  • Gene therapy complements existing pharmacological approaches by enabling targeted delivery of therapeutic genes.